Since the beginning of the year, corporate crypto treasury strategies have been multiplying around the world. This momentum seems to be well underway. Palermo-Manchester City prediction: where to watch the game on TV and streaming
In Palermo, there has been a festive atmosphere since the friendly match was announced. It’s all anyone is talking about in the Sicilian city, and rightly so. Guardiola’s Manchester City is coming, the team that was the strongest in the world—and perhaps still is—full of champions and sensational players.
A friendly match between two teams with the same owners, between two coaches who know each other and who have only one goal for next year: to win. Yes, the Rosanero have signed Inzaghi because he is the wizard of Serie B and always manages to get his teams promoted; as for City, there’s no need to say anything, we already know everything there is to know. So there’s no need for further words.
But what kind of game will it be? Well, on the one hand, the Rosanero will try to limit the damage, while on the other, City, having already secured the result, will not accelerate in any way. We are still talking about a family affair, after all, and two teams that are part of the same project.
Odds comparison
- GOLDBET – Up to €3050 on sports and casino with 200% on your first sports deposit up to €1000 MORE INFO
- SNAI – €15 free + 50% on your first deposit up to €30 MORE INFO
- LOTTOMATICA – Up to €3,050 for sports and casino with 200% on your first sports deposit up to €1,000 MORE INFO
The prediction
In a game full of goals, we also believe that Palermo, perhaps taking advantage of some carelessness from Guardiola’s team, could find the back of the net. It would be sensational.
Probable lineups for Palermo-Manchester City
PALERMO (3-4-2-1): Gomis; Diakite, Peda, Ceccaroni; Gyasi, Blin, Segre, Augello; Di Francesco, Brunori; Pohjanpalo.
MANCHESTER CITY (4-2-3-1): Trafford; Nunes, Dias, Akè, Gvardiol; Reijnders, Gundogan; Silva, Foden, Cherki; Haaland. Possible result: 1-3
MEI Pharma launches the first Litecoin (LTC) corporate treasury
Following their unprecedented inclusion in the development strategies of publicly traded companies, the question is no longer whether, but when the top 50 cryptocurrencies will have their own dedicated corporate treasuries.
A new generation business model is moving from a visionary project, largely driven by Strategy, to a kind of strategic imperative. The goal is not to miss out on the institutional and stock market adoption that this implies.
Clearly, Litecoin founder Charlie Lee has learned his lesson well. He has just participated as a strategic advisor—and new board member—in the launch of the very first corporate treasury dedicated to the LTC cryptocurrency, set up by MEI Pharma.
Litecoin has long been a healthy, scalable, and decentralized currency. By launching this strategy, MEI Pharma is taking a decisive institutional step forward in recognizing Litecoin’s role as both a store of value and an essential component of global financial systems.
Charlie Lee
A fund estimated at over $100 million
To initiate this crypto treasury project, MEI Pharma purchased a total of 929,548 LTC at an average price of $107.58. As a result, its corporate fund dedicated to Litecoin is currently estimated at $110 million at the price of LTC. No significant upturn has been observed in MEIP’s share price in recent days, but it seems important to note a significant rebound of more than 90% since mid-July.
However, one question remains unanswered for the most knowledgeable crypto observers. Why choose Litecoin? The answer provided in MEI Pharma’s press release is divided into three distinct points:
- Flawless reliability, with uninterrupted availability for over 13 years;
- Proven operational efficiency, with minimal fees and fast transaction processing;
- Widespread adoption on platforms such as BitPay, Robinhood, PayPal, and Venmo, with a large network of users and merchants.
This momentum, backed by crypto investment firm GSR, “marks the beginning of a broader institutional treasury initiative for MEI Pharma.” Indeed, the company has announced its intention to “update its identity in the coming weeks” in light of this major development, but also to include the possibility of Litecoin-related mining activity in the near future. This move obviously does not call into question its core pharmaceutical business.